Hend Ahmed El-Hadaad
Overview
Explore the profile of Hend Ahmed El-Hadaad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghazy H, El-Hadaad H, Wahba H, Abbas R, Abbas O
J Gastrointest Cancer
. 2021 Apr;
53(2):446-450.
PMID: 33847917
Background: Worldwide, esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer-related death. At initial diagnosis, about 50% of esophageal cancer patients present with metastasis....
2.
Abdelsalam M, Abu-Hegazy M, El-Hadaad H, Wahba H, Egila H, Esmael A
J Stroke Cerebrovasc Dis
. 2020 Sep;
29(11):105299.
PMID: 32951960
Objectives: The purpose of this study is to assess the risk factors, biomarkers of stroke, mechanism, and outcomes of cerebral infarction among cancerous diseases. Materials & Methods: 156 patients presented...
3.
Wahba H, El-Hadaad H
Cancer Biol Med
. 2015 Jul;
12(2):106-16.
PMID: 26175926
Triple-negative breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal women and is highly prevalent in African American women. TNBC is a term derived from tumors that are...
4.
El-Hadaad H, Wahba H, Roshdy S
J Gastrointest Cancer
. 2015 Mar;
46(2):156-60.
PMID: 25810165
Objective: The objective of this study was to evaluate the results of combined chemoradiotherapy using 5-fluorouracil and cisplatin with radiation in treatment of anal squamous cell carcinoma in terms of...
5.
Abd El Hafez A, El-Hadaad H
Ann Diagn Pathol
. 2013 Dec;
18(2):58-62.
PMID: 24342665
Ovarian cancer is the fourth most common cause of cancer-related death in women. Bmi-1 is a stem cell factor implicated in many human malignancies with poor outcome. Few published reports...
6.
El-Hadaad H, Wahba H, Gamal A, Dawod T
Cancer Biol Med
. 2013 May;
9(3):168-71.
PMID: 23691474
Objective: To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin to radiotherapy confers an advantage for overall survival (OAS), and progression free survival (PFS); to assess the...
7.
El-Hadaad H, Wahba H
J Gastrointest Cancer
. 2013 Apr;
44(3):313-7.
PMID: 23606201
Background: Despite median survival of less than 6 months, there is a significant proportion of advanced pancreatic cancer patients who progress on gemcitabine that remains fit, and these patients are...
8.
Eldeeb H, El-Hadaad H
J Gastrointest Oncol
. 2012 Dec;
3(4):322-5.
PMID: 23205308
The most commonly used treatments for maliganat dysphagia are stenting and radiotherapy (RT). A prospective data of 91 patients with locally advanced or metastatic esophageal cancer who has been treated...
9.
Wahba H, El-Hadaad H, Roshdy S
J Gastrointest Cancer
. 2011 Dec;
43(3):467-71.
PMID: 22147447
Objective: To evaluate toxicity and efficacy of addition of weekly irinotecan to a regimen of chemoradiotherapy of 5-fluorouracil with concurrent pelvic radiation in patients with locally advanced rectal cancer. Patients...
10.
Wahba H, El-Hadaad H, Abd-Ellatif E
Med Oncol
. 2011 Jun;
29(3):1693-8.
PMID: 21706368
Evaluation of the feasibility and efficacy of neoadjuvant concurrent chemoradiotherapy (CRT) with capecitabine and oxaliplatin in patients with locally advanced esophageal cancer. Forty-two patients were eligible for the study. The...